본문으로 건너뛰기
← 뒤로

Efficacy of Intragastric Balloon Placement and Botulinum Toxin Injection in Bariatric Endoscopy.

1/5 보강
Surgical laparoscopy, endoscopy & percutaneous techniques 📖 저널 OA 0% 2021: 0/1 OA 2022: 0/1 OA 2023: 0/2 OA 2024: 0/1 OA 2025: 0/7 OA 2026: 0/6 OA 2021~2026 2020 Vol.30(6) p. 500-503
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
40 patients who received IGBTA in group 1 (P<0.
I · Intervention 중재 / 시술
IGBTA in group 1 (P<0
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The authors recommend the group 3 treatment, provided that nausea, vomiting, and flatulence have a high index of probability in such a treatment. However, when deciding between group 1 and group 2 treatments, the authors recommend opting for group 2 treatment that shows to be more efficient.

Kanlioz M, Ekici U, Tatli F, Karatas T

관련 도메인

📝 환자 설명용 한 줄

[BACKGROUND] To evaluate the results obtained from the combination of intragastric botulinum toxin A (IGBTA), intragastric balloon (IGB), and IGBTA(+)IGB in the treatment of obesity.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P<0.05
  • p-value P<0.001

이 논문을 인용하기

↓ .bib ↓ .ris
APA Kanlioz M, Ekici U, et al. (2020). Efficacy of Intragastric Balloon Placement and Botulinum Toxin Injection in Bariatric Endoscopy.. Surgical laparoscopy, endoscopy & percutaneous techniques, 30(6), 500-503. https://doi.org/10.1097/SLE.0000000000000829
MLA Kanlioz M, et al.. "Efficacy of Intragastric Balloon Placement and Botulinum Toxin Injection in Bariatric Endoscopy.." Surgical laparoscopy, endoscopy & percutaneous techniques, vol. 30, no. 6, 2020, pp. 500-503.
PMID 32740476 ↗

Abstract

[BACKGROUND] To evaluate the results obtained from the combination of intragastric botulinum toxin A (IGBTA), intragastric balloon (IGB), and IGBTA(+)IGB in the treatment of obesity.

[MATERIALS AND METHODS] Three separate treatment groups were set up. IGBTA, IGB, and IGBTA(+)IGB were administered to Group 1, 2, and 3, respectively. The body mass indexes (BMI) of patients were measured before and 6 months after the treatment. The intragroup and intergroup treatment results have been evaluated. P<0.05 was considered significant.

[RESULTS] The mean BMI decreased by 1.6 kg/m in 40 patients who received IGBTA in group 1 (P<0.001), 3.95 kg/m in 42 patients who received IGB in group 2 (P<0.001), and 4.9 kg/m in 39 patients who received IGBTA and IGB in group 3 (P<0.001) after 6 months of treatment. The intolerance because of the application was the highest in group 3, followed by group 2.

[CONCLUSION] The treatment was most successful in group 3 followed by group 2 and group 1, respectively. The authors recommend the group 3 treatment, provided that nausea, vomiting, and flatulence have a high index of probability in such a treatment. However, when deciding between group 1 and group 2 treatments, the authors recommend opting for group 2 treatment that shows to be more efficient.

추출된 의학 개체 (NER)

전체 NER 표 보기
유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 2
기법 endoscopy 내시경 dict 1

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

같은 제1저자의 인용 많은 논문 (2)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능